Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Neurology · Deafness, Dystonia, and Cerebral Hypomyelination Syndrome (DDCH)

BCAP31-related Syndrome (DDCH): A Patient Guide

At a Glance

BCAP31-related syndrome (DDCH) is a rare X-linked condition that can cause early hearing loss, developmental delay, low muscle tone, dystonia, and cerebral hypomyelination. Care focuses on early intervention, symptom management, and coordinated specialist support.

BCAP31-related syndrome, officially known as Deafness, Dystonia, and Cerebral Hypomyelination syndrome (DDCH), is a rare genetic condition that fundamentally affects the way a child’s brain and nervous system develop and function. The name DDCH stands for its three primary features: Deafness (hearing loss), Dystonia (involuntary muscle movements), and Cerebral Hypomyelination (a persistent shortage of the brain’s protective insulation). Historically, you may also see it linked to the term Developmental malformations-deafness-dystonia syndrome, but DDCH or BCAP31-related disorder are the established clinical names [1][2].

This syndrome is an X-linked disorder, meaning the affected gene is located on the X chromosome. Because of this inheritance pattern, the condition primarily affects males, who have only one X chromosome. If a mother is a heterozygous carrier, she has a 50% chance of transmitting the pathogenic variant in each pregnancy. Sons who inherit it are usually affected, while daughters may be unaffected or variably affected. In some cases, the variant is de novo (new in the child), though a family’s genetic counselor must calculate individual recurrence risks [1][3].

At a cellular level, the BCAP31 gene is responsible for a protein that acts as a “quality control manager” within the cell’s factory. When this protein is missing or malfunctioning, it creates a cellular backup that disrupts the development of the brain’s white matter and the sensory pathways of the inner ear [1][3].

In daily life, this condition typically manifests early in infancy as a combination of developmental delays, low muscle tone, and a lack of response to sound. Over time, many children transition from being “floppy” to developing more complex movement challenges, such as the twisting or stiffening postures of dystonia. While these neurological and sensory hurdles are the core of the syndrome, some children also experience elevations in liver enzymes that require regular monitoring. The journey with DDCH is one of careful, symptom-directed management rather than a search for a single cure, focusing on maximizing a child’s ability to communicate and move comfortably within their world [4][5].

Understanding a diagnosis this rare can feel overwhelming, but a clear roadmap can help you navigate the path ahead. In the following pages, we will explore the biological mechanisms behind the syndrome, the specific symptoms to watch for, and how a team of specialists—from neurologists to audiologists—works together to support your child’s unique needs. By focusing on multidisciplinary care and early intervention, families can build a robust support system designed to enhance their child’s quality of life and long-term wellbeing [2][6].

Common questions in this guide

What is BCAP31-related syndrome (DDCH)?
BCAP31-related syndrome, also called Deafness, Dystonia, and Cerebral Hypomyelination syndrome, is a rare genetic condition that affects how a child’s brain, nervous system, and hearing pathways develop. It commonly involves hearing loss, developmental delay, low muscle tone, and movement problems such as dystonia.
Why does DDCH affect boys more often than girls?
DDCH is usually X-linked, meaning the altered BCAP31 gene is on the X chromosome. Boys have one X chromosome and are usually more affected when they inherit the variant, while girls may be unaffected or have a variable degree of symptoms.
What signs may appear in a child with DDCH?
Early signs may include developmental delay, low muscle tone, and little or no response to sound. As a child grows, dystonia with twisting or stiffening postures may develop, and some children have elevated liver enzymes that need monitoring.
How is BCAP31-related syndrome inherited?
If a mother is a heterozygous carrier of a pathogenic BCAP31 variant, each pregnancy has a 50% chance of receiving it. Sons who inherit the variant are usually affected, while daughters may be unaffected or variably affected. Some cases result from a new variant in the child, so a genetic counselor should calculate each family’s individual risk.
What kind of care does a child with DDCH need?
There is no single cure described for DDCH, so care is tailored to the child’s symptoms and goals. A multidisciplinary team may include neurology, audiology, and medical genetics, along with early intervention, communication and movement support, and liver-enzyme monitoring when needed.

Get notified when new evidence is published on Developmental malformations-deafness-dystonia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    Further delineation of BCAP31-linked intellectual disability: description of 17 new families with LoF and missense variants.

    Whalen S, Shaw M, Mignot C, et al.

    European journal of human genetics : EJHG 2021; (29(9)):1405-1417 doi:10.1038/s41431-021-00821-0.

    PMID: 33603160
  2. 2

    Case Report: The first Korean familial case of BCAP31-related deafness, dystonia, and cerebral hypomyelination.

    Suh YA, Hwang J, Seo GH, et al.

    Frontiers in pediatrics 2024; (12()):1488095 doi:10.3389/fped.2024.1488095.

    PMID: 39911770
  3. 3

    BCAP31-associated encephalopathy and complex movement disorder mimicking mitochondrial encephalopathy.

    Albanyan S, Al Teneiji A, Monfared N, Mercimek-Mahmutoglu S

    American journal of medical genetics. Part A 2017; (173(6)):1640-1643 doi:10.1002/ajmg.a.38127.

    PMID: 28332767
  4. 4

    BCAP31-related syndrome: The first de novo report.

    Rinaldi B, Van Hoof E, Corveleyn A, et al.

    European journal of medical genetics 2020; (63(2)):103732 doi:10.1016/j.ejmg.2019.103732.

    PMID: 31330203
  5. 5

    De novo mutation and skewed X-inactivation in girl with BCAP31-related syndrome.

    Kao HJ, Chiang HL, Chen HH, et al.

    Human mutation 2020; (41(10)):1775-1782 doi:10.1002/humu.24080.

    PMID: 32652807
  6. 6

    Whole exome sequencing reveals a dual diagnosis of BCAP31-related syndrome and glutaric aciduria III.

    Huggins E, Jackson DG, Young SP, Kishnani PS

    Molecular genetics and metabolism reports 2024; (40()):101117 doi:10.1016/j.ymgmr.2024.101117.

    PMID: 39101156

This page is for informational purposes only and does not constitute medical advice about a child's BCAP31-related syndrome. Your child's geneticist, neurologist, audiologist, and other specialists can interpret the diagnosis and recommend individualized care.